Company Overview
- Website
- helex.bio
- Employees
- 22
- Founded in
- 2021
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$10B
Recent News & Media
Documenting heritage language experience using questionnaires
- Feb 9, 2024
- frontiersin.org
6 Reasons to Apply for a Research Stay at HeLEX, Oxford
- Jan 18, 2024
- blogs.law.ox.ac.uk
Heat resistance, biodiversity services: sunflowers have a bright future
- Oct 3, 2023
- inrae.fr
Representative LA-ICP-MS image. FFPE samples inserted into a HelEx cell... | Download Scientific Diagram
- Aug 13, 2022
- researchgate.net
Biotech startup Helex brings precision to gene editing
- Jun 24, 2022
- yourstory.com
Figure 5 A Helex device for closure of atrial septal defects.
- Sep 11, 2018
- researchgate.net
Who is Helex
Helex is a biotechnology company based in New York, New York. The company employs 22 people and generates over $10,000 in annual revenue. Helex specializes in developing an epigenetic directed gene editing platform designed to enhance safety. Their focus is on addressing high-burden diseases currently lacking effective treatments. Helex distinguishes itself through its commitment to developing safer gene editing solutions. Their epigenetic directed approach aims to minimize unintended consequences associated with traditional gene editing techniques. For more information, visit their website at helex.bio.
Helex Industry Tags
Companies Similar to Helex
Analyze industry trends and opportunities by examining competitors and companies comparable to Helex, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
10M | 59 | Boston, MA | ||
10M | 27 | Cambridge, MA | 2010 | |
10M | 23 | Waltham, MA | 1999 | |
10M | 2 | Boston, MA | ||
10M | 46 | Woburn, MA |